期刊文献+
共找到138篇文章
< 1 2 7 >
每页显示 20 50 100
Rethinking neurodegenerative diseases:neurometabolic concept linking lipid oxidation to diseases in the central nervous system 被引量:1
1
作者 Steinunn Sara Helgudóttir Anne Skøttrup Mørkholt +7 位作者 Jacek Lichota Preben Bruun-Nyzell Mads Christian Andersen Nanna Marie Juhl Kristensen Amanda Krøger Johansen Mikela Reinholdt Zinn Hulda Maria Jensdóttir John Dirk Vestergaard Nieland 《Neural Regeneration Research》 SCIE CAS CSCD 2024年第7期1437-1445,共9页
Currently,there is a lack of effective medicines capable of halting or reve rsing the progression of neurodegenerative disorde rs,including amyotrophic lateral sclerosis,Parkinson s disease,multiple sclerosis,or Alzhe... Currently,there is a lack of effective medicines capable of halting or reve rsing the progression of neurodegenerative disorde rs,including amyotrophic lateral sclerosis,Parkinson s disease,multiple sclerosis,or Alzheimer s disease.Given the unmet medical need,it is necessary to reevaluate the existing para digms of how to to rget these diseases.When considering neurodegenerative diseases from a systemic neurometabolic perspective,it becomes possible to explain the shared pathological features.This innovative approach presented in this paper draws upon exte nsive research conducted by the authors and researchers worldwide.In this review,we highlight the importance of metabolic mitochondrial dysfunction in the context of neurodegenerative diseases.We provide an overview of the risk factors associated with developing neurodegenerative disorders,including genetic,epigenetic,and environmental fa ctors.Additionally,we examine pathological mechanisms implicated in these diseases such as oxidative stress,accumulation of misfolded proteins,inflammation,demyelination,death of neurons,insulin resistance,dysbiosis,and neurotransmitter disturbances.Finally,we outline a proposal for the restoration of mitochondrial metabolism,a crucial aspect that may hold the key to facilitating curative therapeutic interventions for neurodegenerative disorders in forthcoming advancements. 展开更多
关键词 brain disease carnitine palmitoyl transferase 1 EPIGENETICS metabolism gut microbiome mitochondrial dysfunction NEURODEGENERATION oxidative stress
下载PDF
In vivo imaging of structural,metabolic and functional brain changes in glaucoma 被引量:3
2
作者 Anisha Kasi Muneeb A.Faiq Kevin C.Chan 《Neural Regeneration Research》 SCIE CAS CSCD 2019年第3期446-449,共4页
Glaucoma, the world's leading cause of irreversible blindness, is a condition for which elevated intraocular pressure is currently the only modifiable risk factor. However, the disorder can continue to progress ev... Glaucoma, the world's leading cause of irreversible blindness, is a condition for which elevated intraocular pressure is currently the only modifiable risk factor. However, the disorder can continue to progress even at reduced intraocular pressure. This indicates additional key factors that contribute to the etiopathogenesis. There has been a growing amount of literature suggesting glaucoma as a neurodegenerative disease of the visual system. However, it remains debatable whether the observed pathophysiological conditions are causes or consequences. This review summarizes recent in vivo imaging studies that helped advance the understanding of early glaucoma involvements and disease progression in the brains of humans and experimental animal models. In particular, we focused on the non-invasive detection of early structural and functional brain changes before substantial clinical visual field loss in glaucoma patients; the eye-brain interactions across disease severity; the metabolic changes occurring in the brain's visual system in glaucoma; and, the widespread brain involvements beyond the visual pathway as well as the potential behavioral relevance. If the mechanisms of glaucomatous brain changes are reliably identified, novel neurotherapeutics that target parameters beyond intraocular pressure lowering can be the promise of the near future, which would lead to reduced prevalence of this irreversible but preventable disease. 展开更多
关键词 GLAUCOMA INTRAOCULAR pressure eye-brain-behavior relationship irreversible BLINDNESS magnetic resonance imaging metabolic brain CHANGES sensitivity disease progression
下载PDF
Gut Microbiota and Metabolic Diseases 被引量:1
3
作者 Qianqian Tang Maogong Tang 《Journal of Biosciences and Medicines》 CAS 2022年第11期113-141,共29页
In this review, the characteristics of gut microbiota changes in 11 metabolic diseases, as well as the research progress on their interventions, are summarized. The gut microbiota contributes to metabolic diseases thr... In this review, the characteristics of gut microbiota changes in 11 metabolic diseases, as well as the research progress on their interventions, are summarized. The gut microbiota contributes to metabolic diseases through intestinal mucosal dysfunction, chronic metabolic inflammatory response, gut brain axis imbalance, gene regulation, insulin resistance, and the action of its metabolites. The researches of cause effect relationship and mechanism are relatively few, need further study, expecting a breakthrough in the future to be a new path in the treatment of some metabolic diseases. 展开更多
关键词 Gut Microbiota Microbiota-Gut-brain Axis metabolic diseases Interventions
下载PDF
Perinatal nutritional programming of health and metabolic adult disease 被引量:3
4
作者 Didier Vieau 《World Journal of Diabetes》 SCIE CAS 2011年第9期133-136,共4页
Data indicate that perinatal nutritional insults not onlyhave short-term consequences on the growth velocity of the fetus/neonate but also sensitize to the development of metabolic adult diseases.The pathophysiologica... Data indicate that perinatal nutritional insults not onlyhave short-term consequences on the growth velocity of the fetus/neonate but also sensitize to the development of metabolic adult diseases.The pathophysiological mechanisms involved in the so-called "Developmental Origin of Health and Adult Diseases" are still largely unknown and depend on the type of alteration (nutritional,psychological,endocrine disruptors,etc.),its intensity and duration,species,sex and the time during which it is applied.Perinatal stress,via disturbances of both hy-pothalamo-pituitary-adrenal (HPA) axis and sympathoadrenal-system (SAS),as well as brain-adipose axis and pancreas alterations could play a crucial role.Interestingly,it has been demonstrated that perinatal insults may be transmitted transgenerationally,suggesting that these long-term consequences may be inherited via epigenetic mechanisms.Finally,since the placenta has been demonstrated to be sensitive to perinatal nutritional manipulations,the identification of placental markers may thus represent an important new avenue to identify the more susceptible babies prone to developing meta-bolic diseases. 展开更多
关键词 NUTRITIONAL PROGRAMMING Epigenetic metabolic diseases PERINATAL stress PLACENTA TRANSGENERATIONAL effect Mitochondria brain-adipose axis
下载PDF
Human biochemical genetics: an insight into inborn errors of metabolism
5
作者 YU Chunli SCOTT C. Ronald 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2006年第2期165-166,共2页
Inborn errors of metabolism (IEM) include a broad spectrum of defects of various gene products that affect interme-diary metabolism in the body. Studying the molecular and biochemical mechanisms of those inherited dis... Inborn errors of metabolism (IEM) include a broad spectrum of defects of various gene products that affect interme-diary metabolism in the body. Studying the molecular and biochemical mechanisms of those inherited disorder, systematically summarizing the disease phenotype and natural history, providing diagnostic rationale and methodology and treatment strategy comprise the context of human biochemical genetics. This session focused on: (1) manifestations of representative metabolic disorders; (2) the emergent technology and application of newborn screening of metabolic disorders using tandem mass spec-trometry; (3) principles of managing IEM; (4) the concept of carrier testing aiming prevention. Early detection of patients with IEM allows early intervention and more options for treatment. 展开更多
关键词 inborn errors of metabolism (IEM). Newborn screening (NRS) Disease phenotype and therapy
下载PDF
Microglia lactylation in relation to central nervous system diseases
6
作者 Hui Yang Nan Mo +5 位作者 Le Tong Jianhong Dong Ziwei Fan Mengxian Jia Juanqing Yue Ying Wang 《Neural Regeneration Research》 SCIE CAS 2025年第1期29-40,共12页
The development of neurodegenerative diseases is closely related to the disruption of central nervous system homeostasis.Microglia,as innate immune cells,play important roles in the maintenance of central nervous syst... The development of neurodegenerative diseases is closely related to the disruption of central nervous system homeostasis.Microglia,as innate immune cells,play important roles in the maintenance of central nervous system homeostasis,injury response,and neurodegenerative diseases.Lactate has been considered a metabolic waste product,but recent studies are revealing ever more of the physiological functions of lactate.Lactylation is an important pathway in lactate function and is involved in glycolysis-related functions,macrophage polarization,neuromodulation,and angiogenesis and has also been implicated in the development of various diseases.This review provides an overview of the lactate metabolic and homeostatic regulatory processes involved in microglia lactylation,histone versus non-histone lactylation,and therapeutic approaches targeting lactate.Finally,we summarize the current research on microglia lactylation in central nervous system diseases.A deeper understanding of the metabolic regulatory mechanisms of microglia lactylation will provide more options for the treatment of central nervous system diseases. 展开更多
关键词 brain central nervous system GLYCOLYSIS immune response INFLAMMATION lactate metabolism LACTATE lactylation MICROGLIA neurodegenerative diseases
下载PDF
Lactate metabolism in neurodegenerative diseases 被引量:6
7
作者 Chaoguang Yang Rui-Yuan Pan +1 位作者 Fangxia Guan Zengqiang Yuan 《Neural Regeneration Research》 SCIE CAS CSCD 2024年第1期69-74,共6页
Lactate,a byproduct of glycolysis,was thought to be a metabolic waste until the discovery of the Warburg effect.Lactate not only functions as a metabolic substrate to provide energy but can also function as a signalin... Lactate,a byproduct of glycolysis,was thought to be a metabolic waste until the discovery of the Warburg effect.Lactate not only functions as a metabolic substrate to provide energy but can also function as a signaling molecule to modulate cellular functions under pathophysiological conditions.The Astrocyte-Neuron Lactate Shuttle has cla rified that lactate plays a pivotal role in the central nervous system.Moreover,protein lactylation highlights the novel role of lactate in regulating transcription,cellular functions,and disease development.This review summarizes the recent advances in lactate metabolism and its role in neurodegenerative diseases,thus providing optimal pers pectives for future research. 展开更多
关键词 Alzheimer's disease Astrocyte-Neuron Lactate Shuttle brain central nervous system glucose metabolism GLYCOLYSIS NEUROINFLAMMATION Parkinson's disease protein lactylation signaling molecule
下载PDF
Potential role of tanycyte-derived neurogenesis in Alzheimer's disease
8
作者 Guibo Qi Han Tang +2 位作者 Jianian Hu Siying Kang Song Qin 《Neural Regeneration Research》 SCIE CAS 2025年第6期1599-1612,共14页
Tanycytes, specialized ependymal cells located in the hypothalamus, play a crucial role in the generation of new neurons that contribute to the neural circuits responsible for regulating the systemic energy balance. T... Tanycytes, specialized ependymal cells located in the hypothalamus, play a crucial role in the generation of new neurons that contribute to the neural circuits responsible for regulating the systemic energy balance. The precise coordination of the gene networks controlling neurogenesis in naive and mature tanycytes is essential for maintaining homeostasis in adulthood. However, our understanding of the molecular mechanisms and signaling pathways that govern the proliferation and differentiation of tanycytes into neurons remains limited. This article aims to review the recent advancements in research into the mechanisms and functions of tanycyte-derived neurogenesis. Studies employing lineage-tracing techniques have revealed that the neurogenesis specifically originating from tanycytes in the hypothalamus has a compensatory role in neuronal loss and helps maintain energy homeostasis during metabolic diseases. Intriguingly,metabolic disorders are considered early biomarkers of Alzheimer's disease. Furthermore,the neurogenic potential of tanycytes and the state of newborn neurons derived from tanycytes heavily depend on the maintenance of mild microenvironments, which may be disrupted in Alzheimer's disease due to the impaired blood–brain barrier function.However, the specific alterations and regulatory mechanisms governing tanycyte-derived neurogenesis in Alzheimer's disease remain unclear. Accumulating evidence suggests that tanycyte-derived neurogenesis might be impaired in Alzheimer's disease, exacerbating neurodegeneration. Confirming this hypothesis, however, poses a challenge because of the lack of long-term tracing and nucleus-specific analyses of newborn neurons in the hypothalamus of patients with Alzheimer's disease. Further research into the molecular mechanisms underlying tanycyte-derived neurogenesis holds promise for identifying small molecules capable of restoring tanycyte proliferation in neurodegenerative diseases. This line of investigation could provide valuable insights into potential therapeutic strategies for Alzheimer's disease and related conditions. 展开更多
关键词 Alzheimer's disease blood–brain barrier ependymoglial cells HYPOTHALAMUS metabolic diseases neural stem cells NEUROGENESIS neuroinflammatory diseases NEURONS TANYCYTE
下载PDF
The novel roles of circular RNAs in metabolic organs 被引量:3
9
作者 Zhi-Chun Zhang Xiao-Long Guo Xi Li 《Genes & Diseases》 SCIE 2018年第1期16-23,共8页
Circular RNAs(circRNAs)with a covalently closed loop structure which was different with linear RNAs,recently re-merged as novel regulator and exerted function in multiple biological processes.Through deep RNA sequenci... Circular RNAs(circRNAs)with a covalently closed loop structure which was different with linear RNAs,recently re-merged as novel regulator and exerted function in multiple biological processes.Through deep RNA sequencing(RNA-seq)technology coupled with bioinformatic analyses,a number of circRNAs has been identified.Moreover,circRNAs exhibit tissue-and development-specific expression indicating their potential biological significance.Actually,function of circRNAs as miRNA sponge has been well demonstrated in some diseases,besides,circRNAs also could function as RNA binding protein sponge and regulate alternative splicing and gene transcription.Notably,Emerging evidences showed that circRNAs played a pivotal role on the development of diseases including atherosclerotic vascular disease,neurological disorders and liver diseases,and served as diagnostic or predictive biomarkers of some diseases.This review mainly discusses the current advance of circRNAs as regulator involved in many diseases,and highlights circRNAs which have been well elucidated biological and pathogenic mechanism. 展开更多
关键词 brain Circular RNAs Liver metabolic disease METABOLISM
原文传递
Physical Activity, Mediterranean Diet and Biomarkers-Assessed Risk of Alzheimer’s: A Multi-Modality Brain Imaging Study 被引量:4
10
作者 Dawn C. Matthews Michelle Davies +9 位作者 John Murray Schantel Williams Wai H. Tsui Yi Li Randolph D. Andrews Ana Lukic Pauline McHugh Shankar Vallabhajosula Mony J. de Leon Lisa Mosconi 《Advances in Molecular Imaging》 2014年第4期43-57,共15页
Increased physical activity and higher adherence to a Mediterranean-type diet (MeDi) have been independently associated with reduced risk of Alzheimer’s disease (AD). Their association has not been investigated with ... Increased physical activity and higher adherence to a Mediterranean-type diet (MeDi) have been independently associated with reduced risk of Alzheimer’s disease (AD). Their association has not been investigated with the use of biomarkers. This study examines whether, among cognitively normal (NL) individuals, those who are less physically active and show lower MeDi adherence have brain biomarker abnormalities consistent with AD. Methods: Forty-five NL individuals (age 54 ± 11, 71% women) with complete leisure time physical activity (LTA), dietary information, and cross-sectional 3D T1-weigthed MRI, 11C-Pittsburgh Compound B (PiB) and 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) scans were examined. Voxel-wise multivariate partial least square (PLS) regression was used to examine the effects of LTA, MeDi and their interaction on brain biomarkers. Age, gender, ethnicity, education, caloric intake, BMI, family history of AD, Apolipoprotein E (APOE) genotype, presence of hypertension and insulin resistance were examined as confounds. Subjects were dichotomized into more and less physically active (LTA+ vs. LTA-;n = 21 vs. 24), and into higher vs. lower MeDi adherence groups (n = 18 vs. 27) using published scoring methods. Spatial patterns of brain biomarkers that represented the optimal association between the images and the groups were generated for all modalities using voxel-wise multivariate Partial Least Squares (PLS) regression. Results: Groups were comparable for clinical and neuropsychological measures. Independent effects of LTA and MeDi factors were observed in AD-vulnerable brain regions for all modalities (p β load and lower glucose metabolism) were observed in LTA- compared to LTA+ subjects, and in MeDi- as compared to MeDi+ subjects. A gradient effect was observed for all modalities so that LTA+/MeDi+ subjects had the highest and LTA+/MeDi+ subjects had the lowest AD-burden (p < 0.001), although the LTA × MeDi interaction was significant only for FDG measures (p < 0.03). Adjusting for covariates did not attenuate these relationships. Conclusion: Lower physical activity and MeDi adherence were associated with increased brain AD-burden among NL individuals, in-dicating that lifestyle factors may modulate AD risk. Studies with larger samples and longitudinal evaluations are needed to determine the predictive power of the observed associations. 展开更多
关键词 Alzheimer’s Disease Mediterranean DIET Physical activity PET Imaging AMYLOID GLUCOSE Metabolism MRI Early Detection brain Aging
下载PDF
Are human dental papilla-derived stem cell and human brain-derived neural stem cell transplantations suitable for treatment of Parkinson’s disease? 被引量:5
11
作者 Hyung Ho Yoon Joongkee Min +6 位作者 Nari Shin Yong Hwan Kim Jin-Mo Kim Yu-Shik Hwang Jun-Kyo Francis Suh Onyou Hwang Sang Ryong Jeon 《Neural Regeneration Research》 SCIE CAS CSCD 2013年第13期1190-1200,共11页
Transplantation of neural stem cells has been reported as a possible approach for replacing impaired dopaminergic neurons. In this study, we tested the efficacy of early-stage human dental papilla-derived stem cells a... Transplantation of neural stem cells has been reported as a possible approach for replacing impaired dopaminergic neurons. In this study, we tested the efficacy of early-stage human dental papilla-derived stem cells and human brain-derived neural stem cells in rat models of 6-hydroxydopamine-induced Parkinson's disease. Rats received a unilateral injection of 6-hydroxydopamine into right medial forebrain bundle, followed 3 weeks later by injections of PBS, early-stage human dental papilla-derived stem cells, or human brain-derived neural stem cells into the ipsilateral striatum. All of the rats in the human dental papilla-derived stem cell group died from tumor formation at around 2 weeks following cell transplantation. Postmortem examinations revealed homogeneous malignant tumors in the striatum of the human dental papilla-derived stem cell group. Stepping tests revealed that human brain-derived neural stem cell transplantation did not improve motor dysfunction. In apomorphine-induced rotation tests, neither the human brain-derived neural stem cell group nor the control groups (PBS injection) demonstrated significant changes. Glucose metabolism in the lesioned side of striatum was reduced by human brain-derived neural stem cell transplantation. [18F]-FP-CIT PET scans in the striatum did not demonstrate a significant increase in the human brain-derived neural stem cell group. Tyrosine hydroxylase (dopaminergic neuronal marker) staining and G protein-activated inward rectifier potassium channel 2 (A9 dopaminergic neuronal marker) were positive in the lesioned side of striatum in the human brain-derived neural stem cell group. The use of early-stage human dental papilla-derived stern cells confirmed its tendency to form tumors. Human brain-derived neural stem cells could be partially differentiated into dopaminergic neurons, but they did not secrete dopamine. 展开更多
关键词 neural regeneration stern cells cell transplantation glucose metabolism human brain-derivedneural stem cells human dental papilla-derived stem cells Parkinson's disease positron emissiontomography grants-supported paper NEUROREGENERATION
下载PDF
脑脊液特征指标辅助结核性脑膜炎快速筛查的效果评估
12
作者 汪晨媛 王珊珊 +4 位作者 王赛楠 邵戈 曹佳颐 熊海燕 胡屹 《中国防痨杂志》 CAS CSCD 北大核心 2024年第3期311-317,共7页
目的:探索利用若干脑脊液特征指标辅助提高敏感度,实现结核性脑膜炎(tuberculous meningitis,TBM)的快速筛查和早期治疗控制。方法:2011—2019年期间,依据纳入排除标准,从江苏省苏州市、四川省自贡市和贵州省贵阳市的结核病定点医疗机... 目的:探索利用若干脑脊液特征指标辅助提高敏感度,实现结核性脑膜炎(tuberculous meningitis,TBM)的快速筛查和早期治疗控制。方法:2011—2019年期间,依据纳入排除标准,从江苏省苏州市、四川省自贡市和贵州省贵阳市的结核病定点医疗机构收治的383例疑似TBM患者中,随机筛选100例临床诊断TBM患者,并按年龄、性别1∶1配对抽取100例非TBM患者,收集脑脊液白细胞计数、乳酸盐、蛋白总量、腺苷脱氨酶、葡萄糖等生化指标,并采用超高通量液相色谱法分离患者脑脊液代谢物,通过偏正交最小二乘判别法分析(OPLS-DA)筛选在不同类型患者中分布具有差异的生化和代谢物指标,通过机器学习构建决策树模型(boosted-CART),评估特征指标对于快速筛查各类型TBM患者的效果。结果:以P<0.05、OPLS-DA模型变量权重值>1和代谢物组间表达量差异倍数>1为标准,利用boosted-CART模型筛选脑脊液L-谷氨酰胺和葡萄糖水平作为特征指标,其cut-off值分别为607.06mmol/L(L-谷氨酰胺)和60.03mg/dl(葡萄糖)。上述两项指标联用,可将检出很可能和可能TBM患者的敏感度从66.7%(95%CI:24.1%~94.0%)提升至83.3%(95%CI:36.5%~99.1%),AUC值从0.667(95%CI:0.444~0.889)提升至0.708(95%CI:0.494~0.923),但效果不明显(Z=0.261,P>0.05)。结论:脑脊液L-谷氨酰胺和葡萄糖指标可提高TBM快速筛查的敏感度,利于TBM早诊早治和控制结核病传播。 展开更多
关键词 结核 脑膜 脑脊液 脑部疾病 代谢 早期诊断 传染病控制
下载PDF
^(18)F-FDG与^(18)F-DPA-714 Micro PET/CT显像评价生酮饮食治疗阿尔茨海默病小鼠大脑代谢及神经炎症
13
作者 黄禹豪 曾薪宇 +3 位作者 陈飞 詹友胜 杨凡慧 李素平 《中国医学影像学杂志》 CSCD 北大核心 2024年第5期431-438,共8页
目的探讨生酮饮食(KD)能否通过调节阿尔茨海默病模型小鼠大脑代谢及神经炎症促进认知。材料与方法将20只APP/PS1雄性小鼠随机分为KD组(APP/PS1+KD)与普通饮食组(APP/PS1),每组10只;同时以10只野生型C57BL/6雄性小鼠作为对照组。使用生... 目的探讨生酮饮食(KD)能否通过调节阿尔茨海默病模型小鼠大脑代谢及神经炎症促进认知。材料与方法将20只APP/PS1雄性小鼠随机分为KD组(APP/PS1+KD)与普通饮食组(APP/PS1),每组10只;同时以10只野生型C57BL/6雄性小鼠作为对照组。使用生酮饲料喂养APP/PS1+KD组,普通饲料喂养APP/PS1组和对照组,共4个月。连续喂养4周、4个月后,记录小鼠的血酮,并使用Morris水迷宫评估小鼠认知,再行^(18)F-FDG和^(18)F-DPA-714 micro PET/CT分别评估KD对阿尔茨海默病小鼠各脑区葡萄糖代谢及神经炎症的影响;完成PET/CT显像后取脑组织,选择海马CA1区制成石蜡切片进行免疫荧光检测胶质纤维酸性蛋白、离子化钙结合适配分子表达情况。结果4个月时,与对照组相比,APP/PS1组第3~4天逃避潜伏期显著延长(P<0.01、P<0.05)。与对照组相比,APP/PS1组在纹状体、海马、背侧丘脑、中央灰质、上丘、嗅球、中脑等脑区对^(18)F-FDG的标准化摄取值比值显著下降(P<0.05或P<0.01);与APP/PS1组相比,APP/PS1+KD组海马、背侧丘脑对^(18)F-FDG的标准化摄取值比值显著升高(P<0.01)。与对照组相比,APP/PS1组纹状体、海马、下丘脑等脑区对^(18)F-DPA-714的标准化摄取值比值显著上升(P<0.05或P<0.001);与APP/PS1组相比,APP/PS1+KD组降低了海马区相对^(18)F-DPA-714摄取(P<0.01)。与对照组、APP/PS1+KD组相比,APP/PS1组小鼠脑(海马)胶质纤维酸性蛋白、离子化钙结合适配分子表达显著升高(P均<0.01)。结论KD可通过提高APP/PS1小鼠大脑代谢并抑制神经炎症,促进其认知行为学改善。 展开更多
关键词 生酮饮食 阿尔茨海默病 正电子发射断层扫描/计算机断层扫描 大脑代谢 神经炎症
下载PDF
不同剂量奥氮平治疗脑器质性和躯体疾病致精神障碍患者的效果 被引量:2
14
作者 王静 傅启伟 +1 位作者 梁丁方 周小焕 《西北药学杂志》 CAS 2024年第2期139-143,共5页
目的探讨不同剂量奥氮平治疗脑器质性和躯体疾病所致精神障碍患者的效果。方法以收治的108例脑器质性和躯体疾病致精神障碍患者为研究对象,用随机数字表法分为对照组和观察组,每组54例。对照组予以大剂量奥氮平片治疗,观察组予以小剂量... 目的探讨不同剂量奥氮平治疗脑器质性和躯体疾病所致精神障碍患者的效果。方法以收治的108例脑器质性和躯体疾病致精神障碍患者为研究对象,用随机数字表法分为对照组和观察组,每组54例。对照组予以大剂量奥氮平片治疗,观察组予以小剂量奥氮平片治疗。2组均治疗8周。比较2组治疗后的效果,治疗前后阳性与阴性症状量表(positive and negative symptom scale,PANSS)评分、神经功能缺损评分量表(national institute of health strokescale,NIHSS)评分、日常生活能力量表(activity of daily living,ADL)评分、简明精神病评定量表(brief psychiatric rating scale,BPRS)评分和糖脂代谢指标。结果治疗后,观察组的临床总有效率高于对照组;2组阳性症状评分、阴性症状评分、一般精神病理评分、总评分、NIHSS评分及BPRS评分均降低,且观察组低于对照组(P<0.05),ADL评分升高,且观察组高于对照组(P<0.05);2组血清总胆固醇(total cholesterol,TC)、低密度脂蛋白-胆固醇(low-density lipoprotein cholesterol,LDL-C)、三酰甘油(triglycerides,TG)、空腹血糖(fasting blood glucose,FBG)、空腹胰岛素(fasting insulin,FINS)、稳态胰岛素评价指数(homeostasis model assessment of insulin resistance,HOMA-IR)及餐后2 h血糖(2 hours postprandial blood glucose,2 h PBG)水平均升高,且观察组低于对照组,血清高密度脂蛋白-胆固醇(high-density lipoprotein cholesterol,HDL-C)水平均降低,且观察组高于对照组(P<0.05)。结论脑器质性和躯体疾病所致精神障碍患者应用小剂量奥氮平能够有效提高其临床治疗效果及日常生活能力,改善其精神状况、临床症状及神经功能,同时对患者糖脂代谢的影响较小。 展开更多
关键词 奥氮平 精神障碍 脑器质性 躯体疾病 神经功能 糖脂代谢
下载PDF
高糖诱导HT-22小鼠海马神经元代谢记忆细胞模型的构建及影响
15
作者 段云峰 许永劼 +4 位作者 杨婷婷 黄昶煜东 朱丽英 李兴 潘卫 《天津医药》 CAS 2024年第1期44-50,共7页
目的 体外构建高糖诱导HT-22小鼠海马神经元“代谢记忆”细胞模型,探究“代谢记忆”对HT-22细胞凋亡和组蛋白乙酰化的影响。方法 以高糖培养基(葡萄糖浓度为55 mmol/L)和常规糖培养基(葡萄糖浓度为25 mmol/L)培养HT-22细胞,分为常糖组(N... 目的 体外构建高糖诱导HT-22小鼠海马神经元“代谢记忆”细胞模型,探究“代谢记忆”对HT-22细胞凋亡和组蛋白乙酰化的影响。方法 以高糖培养基(葡萄糖浓度为55 mmol/L)和常规糖培养基(葡萄糖浓度为25 mmol/L)培养HT-22细胞,分为常糖组(NG 4、6、8组,25 mmol/L葡萄糖分别培养4、6、8 d),高糖组(HG 4、6、8组,高糖培养4、6、8 d),代谢记忆组(HG2NG2、HG2NG4、HG2NG6、HG4NG2、HG4NG4组,即高糖2 d转25 mmol/L葡萄糖培养2、4或6 d,高糖4 d转25 mmol/L葡萄糖培养2 d或4 d)。CCK-8法检测细胞活力变化,检测细胞培养上清液中乳酸脱氢酶(LDH)释放量,筛选出建立“代谢记忆”模型的最佳作用时间。后续将细胞分为NG4组、NG8组、HG4组、HG4NG4组和HG8组,光学显微镜观察各组细胞形态;流式细胞术检测各组细胞凋亡率;酶联免疫吸附试验(ELISA)检测去乙酰化酶(HDAC)和组蛋白乙酰转移酶(HAT)活性;Western blot检测组蛋白去乙酰化酶4(HDAC4)、B淋巴细胞瘤-2(Bcl-2)、Bcl-2相关X蛋白(Bax)和胱天蛋白酶3(Caspase-3)蛋白表达情况。结果 HG4NG4组为理想的高糖“代谢记忆”细胞模型;NG4、NG8组细胞交织成致密网状,生长状态良好,细胞呈梭形,突触结构明显。而HG4、8组细胞胞体变圆,突触结构消失,生长受抑,HG4NG4组细胞数量增多但形态受损;流式细胞术结果显示,与NG8组相比,HG8、HG4NG4组凋亡率增加(P<0.05);ELISA结果表明,与NG8组相比,HG8组及HG4NG4组HAT和HDAC的水平均增高(P<0.05),与HG8组相比,HG4NG4组HAT和HDAC差异无统计学意义;Western blot结果显示,与NG8组相比,HG8组、HG4NG4组HDAC4、Bax和Caspase-3蛋白表达增加,Bcl-2蛋白表达水平降低(P<0.05),与HG8组相比,HG4NG4组蛋白表达差异无统计学意义。结论 HT-22小鼠海马神经元细胞经高糖55 mmol/L培养4 d后,再以25 mmol/L葡萄糖培养4 d是理想的高糖“代谢记忆”细胞模型。其机制可能与高糖模型中HDAC、HAT活性及HDAC4表达升高有关。 展开更多
关键词 糖尿病 脑疾病 细胞凋亡 组蛋白乙酰转移酶 组蛋白脱乙酰基酶类 HT-22 代谢记忆
下载PDF
肌病型肉碱棕榈酰转移酶Ⅱ缺乏症1例并文献复习
16
作者 陆光双 夏明农 +4 位作者 程云 胡杰 李文博 张帆 杨武 《精准医学杂志》 2024年第5期448-451,共4页
目的探讨肌病型肉碱棕榈酰转移酶Ⅱ(CPTⅡ)缺乏症基因型-临床表型特点,以提高临床对该病的认识。方法分析1例肌病型CPTⅡ缺乏症患者临床资料,包括基因检测结果、诊治和随访情况,复习文献并总结CPTⅡ缺乏症临床特点和疾病诊治状况。结果... 目的探讨肌病型肉碱棕榈酰转移酶Ⅱ(CPTⅡ)缺乏症基因型-临床表型特点,以提高临床对该病的认识。方法分析1例肌病型CPTⅡ缺乏症患者临床资料,包括基因检测结果、诊治和随访情况,复习文献并总结CPTⅡ缺乏症临床特点和疾病诊治状况。结果患儿,女,10月,急性肠炎入院,血肌酸激酶、肌红蛋白水平显著升高,其父亲既往有经常运动后乏力及解酱油色小便病史,该患儿及其父亲均检测到CPT2基因杂合致病突变c.989dupTp.(Ile332fs),确诊肌病型CPTⅡ缺乏症;予控制感染、补充大量碳水化合物等治疗,患儿血肌酸激酶、肌红蛋白水平恢复正常,出院随访情况良好。结论肌病型CPTⅡ缺乏症是影响骨骼肌脂质代谢常见疾病,也是遗传性肌红蛋白尿常见病因,但症状非常隐蔽,临床上易被忽视,当遇到患者反复血肌酸激酶升高伴运动不耐受、肌红蛋白尿等或有家族史时,需考虑到该病。 展开更多
关键词 肉碱O-软脂酰转移酶 代谢缺陷 先天性 肌疾病 突变 肌红蛋白尿
下载PDF
BASP1功能与人类疾病的研究进展
17
作者 伍晓棋 王丹玲 《中国动脉硬化杂志》 CAS 2024年第5期444-450,共7页
脑膜黏附信号蛋白1(BASP1)最初在大鼠的大脑中被发现,广泛表达于大脑、心脏、口腔、皮肤、胃、肾脏等多个人体器官。BASP1蛋白序列在进化上保守,以固有无序蛋白(IDP)的形式参与了生物体内细胞信号传递、细胞迁移、细胞凋亡、基因转录等... 脑膜黏附信号蛋白1(BASP1)最初在大鼠的大脑中被发现,广泛表达于大脑、心脏、口腔、皮肤、胃、肾脏等多个人体器官。BASP1蛋白序列在进化上保守,以固有无序蛋白(IDP)的形式参与了生物体内细胞信号传递、细胞迁移、细胞凋亡、基因转录等进程,与神经发育、肾脏发育、生殖细胞形成等一系列病理生理过程密切相关,在糖脂代谢疾病和肿瘤类疾病中BASP1发挥了极其重要的作用,被认为是极具潜力的疾病治疗靶点及分子诊断标志物。 展开更多
关键词 脑膜黏附信号蛋白1 固有无序蛋白 糖脂代谢疾病 肿瘤
下载PDF
老年人群代谢综合征的患病率及其与心脑血管病的关系 被引量:22
18
作者 何耀 封康 +4 位作者 王洁 常青 姜勇 范利 李小鹰 《中华老年心脑血管病杂志》 CAS 北大核心 2006年第9期597-600,共4页
目的调查北京城区老年人群中代谢综合征(MS)的患病率,并探讨其与心血管疾病的关系。方法人群为基础的横断面现况研究。2334例老年人(年龄60~95岁;男性943例,女性1391例)为北京市海淀区万寿路地区分层整群抽样样本,占万寿路地... 目的调查北京城区老年人群中代谢综合征(MS)的患病率,并探讨其与心血管疾病的关系。方法人群为基础的横断面现况研究。2334例老年人(年龄60~95岁;男性943例,女性1391例)为北京市海淀区万寿路地区分层整群抽样样本,占万寿路地区老年人口的11,4%、MS的诊断标准为美国胆固醇教育计划(NCEP ATPⅢ)和国际糖尿病联盟(IDF)2005标准。冠心病和脑卒中的定义为WHO-MONICA标准.结果北京城区老年人群中MS患病率:NCEP标准为30.5%(男性17.6%,女性39.2%);IDF标准为46.3%(男性34.8%,女性54.1%)。无论采用NCEP或IDF、诊断标准,具有MS的人群中,冠心病和脑卒中的患病危险均明显增高约50%。在符合IDF标准而不符合NCEP标准的人群中(n=436,18.7%),冠心病和脑卒中的危险度亦有显著增高。其OR(95%CI)分别是1.65(1.31~2.09)和1.53(1.13~2.06)。结论MS在北京城市老年人群中(尤其是女性)患病率较高。IDF标准比NCEP更适合评估和筛选中国MS中的心血管病危险人群。 展开更多
关键词 代谢疾病 患病率 心血管疾病 脑疾病 危险因素
下载PDF
脑葡萄糖代谢显像诊断缺血性脑血管病 被引量:20
19
作者 何洁 许英路 +3 位作者 翟勇 张人玲 张顺英 孙素花 《中国医学影像技术》 CSCD 北大核心 2005年第4期625-628,共4页
目的 通过比较脑血流灌注显像和脑葡萄糖代谢显像,观察脑葡萄糖代谢显像在缺血性脑血管病诊断中的价值。方法 对43例缺血性脑血管病患者和5例正常人的脑18氟脱氧葡萄糖(18 F FDG)符合线路显像与99 锝m 双半胱氨酸乙酯(99Tcm ECD)脑血... 目的 通过比较脑血流灌注显像和脑葡萄糖代谢显像,观察脑葡萄糖代谢显像在缺血性脑血管病诊断中的价值。方法 对43例缺血性脑血管病患者和5例正常人的脑18氟脱氧葡萄糖(18 F FDG)符合线路显像与99 锝m 双半胱氨酸乙酯(99Tcm ECD)脑血流灌注显像进行对比分析。结果 脑葡萄糖代谢显像的灵敏度、特异度分别为71.81%、95.71%,脑血流灌注显像的灵敏度、特异度分别为57.45%(P<0.01)、92.86%(P>0.05)。结论 在诊断缺血性脑血管病中脑葡萄糖代谢显像较脑血流灌注显像更灵敏,故可用于早期诊断缺血性脑血管病。 展开更多
关键词 体层摄影术 发射型计算机 脑葡萄糖代谢显像 脑血流灌注显像 脑血管病
下载PDF
遗传性代谢病146例临床研究 被引量:3
20
作者 彭晓音 朱彦丽 +2 位作者 王立文 李尔珍 杨健 《临床儿科杂志》 CAS CSCD 北大核心 2010年第7期666-669,共4页
目的探讨遗传性代谢病患儿的疾病谱、年龄特点及临床症状。方法对2003年1月—2007年12月在首都儿科研究所附属儿童医院住院的146例遗传性代谢病患儿的临床资料进行回顾性分析。依据患儿典型症状结合特殊生化检测、尿GC/MS、酶学、基因... 目的探讨遗传性代谢病患儿的疾病谱、年龄特点及临床症状。方法对2003年1月—2007年12月在首都儿科研究所附属儿童医院住院的146例遗传性代谢病患儿的临床资料进行回顾性分析。依据患儿典型症状结合特殊生化检测、尿GC/MS、酶学、基因学检测、肌肉活检、影像学及实验性治疗等作出实验室诊断或临床诊断。结果检出遗传性代谢病共9大类17个病种,有机酸血症检出率占首位(36.3%),其次为线粒体病(16.4%)。1岁内出现症状者91例(62.3%),确诊53例(36.3%);~3岁出现症状者21例(14.4%),确诊40例(27.4%);~6岁出现症状者16例(11.0%),确诊15例(10.3%);>6岁出现症状者18例(12.3%),确诊38例(26.0%)。146例主要表现为智力运动发育落后或倒退(85.9%)、肌张力异常(51.4%)、惊厥(41.8%)、肝大(30.8%)、血液系统异常(24.7%)、共济失调(12.3%)。结论儿童期发病的遗传性代谢病病种多,其中有机酸血症检出率最高;遗传性代谢病患儿症状出现年龄早、确诊年龄滞后,且随年龄增长发病人数减少;对以智力运动发育落后/倒退、惊厥、肌张力异常就诊的患儿应注意除外遗传性代谢病。 展开更多
关键词 遗传性代谢病 疾病谱 年龄 临床症状
下载PDF
上一页 1 2 7 下一页 到第
使用帮助 返回顶部